Sanofi and GSK selected for Operation Warp Speed to supply United States Government with 100 million doses of COVID-19 vaccine
For media and investors only
Issued: London, UK and Paris, France
- Promising vaccine candidate selected by U.S. government?s Operation Warp Speed
- U.S. government to provide funding up to $2.1 billion for development including clinical trials, manufacturing, scale-up and delivery of an initial 100 million doses
- Ongoing discussions with European Commission ? with France and Italy on the negotiation team - and other governments to ensure global access to a novel coronavirus vaccine